Dexcom (DXCM) EBIT Growth (5y) (2015 - 2026)
Powered by 
Analysis
Dexcom (DXCM) EBIT Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.70 Bn | 18.30 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.81% |
| Mar 31, 2026 | 40.94% |
| Dec 31, 2025 | 25.44% |
| Sep 30, 2025 | 20.84% |
| Jun 30, 2025 | 25.68% |
| Mar 31, 2025 | 31.81% |
| Dec 31, 2024 | 13.23% |
| Sep 30, 2024 | 22.10% |
| Jun 30, 2024 | 188.40% |
| Mar 31, 2024 | 55.26% |
| Dec 31, 2023 | 27.11% |
| Sep 30, 2023 | 71.38% |
| Jun 30, 2023 | 94.93% |
| Mar 31, 2023 | 28.75% |
| Dec 31, 2022 | 59.89% |
| Sep 30, 2022 | 212.29% |
| Jun 30, 2022 | 50.27% |
| Mar 31, 2022 | 24.76% |
| Dec 31, 2021 | 15.98% |
| Sep 30, 2021 | 53.04% |